410 results on '"PACIOTTI, Marco"'
Search Results
2. Robotic Assisted Laparoscopy in the Treatment of Genito-Urinary Prolapse
3. Training and Education in Robotic Surgery: Recommendations of ERUS (EAU Robotic Urology Section)
4. Robotic assisted vs open radical cystectomy: an updated systematic review and meta-analysis
5. Development and validation of metrics for a new RAPN training model
6. Patterns of adoption of different robotic systems at tertiary care institutions in the early dissemination phase: a junior ERUS/YAU working group in robotic surgery study
7. Is multiparametric MRI always needed in biopsy-naïve patients with abnormal digital rectal examination? A single-institutional experience combining clinical and micro-ultrasonography-based factors to optimize prostate cancer detection
8. Transitioning from Da Vinci Si to Xi: assessing surgical outcomes at a high-volume robotic center
9. Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study
10. Robot-assisted sutureless partial nephrectomy for the treatment of fifteen bilateral renal masses in a patient with Von Hippel–Lindau syndrome: a case report from a high-volume robotic center
11. Atlas of Intracorporeal Orthotopic Neobladder Techniques After Robot-assisted Radical Cystectomy and Systematic Review of Clinical Outcomes
12. Robot-assisted Radical Prostatectomy Performed with Different Robotic Platforms: First Comparative Evidence Between Da Vinci and HUGO Robot-assisted Surgery Robots
13. Robot-assisted adrenalectomy: Step-by-step technique and surgical outcomes at a high-volume robotic center
14. The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis
15. Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer
16. International consensus panel for transurethral resection of bladder tumours metrics: assessment of face and content validity
17. Estimating the impact of enhanced care at minority‐serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers
18. MP31-03 DECODING CLINICALLY SIGNIFICANT PROSTATE CANCER IN BIOPSY NAIVE PATIENTS: A MACHINE LEARNING APPROACH FROM A TERTIARY REFERRAL CENTER
19. PD13-12 DIAGNOSTIC PERFORMANCE OF MICROULTRASOUND AT CONFIRMATORY RECLASSIFICATION BIOPSY IN PATIENTS UNDER ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
20. MP71-12 EVALUATING THE OUTCOMES OF BLADDER-SPARING TREATMENTS (BST) IN PATIENTS WITH BCG-UNRESPONSIVE AND BCG-EXPOSED NMIBC
21. PD50-09 A NOMOGRAM TO PREDICT LYMPHNODE INVOLVEMENT IN CANDIDATES TO ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH IT3 PROSTATE CANCER ON PREOPERATIVE MULTIPARAMETRIC MRI AS UNIQUE HIGH-RISK FEATURE
22. PD45-07 EXTERNAL VALIDATION OF THE AMSTERDAM-BRISBANE-SYDNEY NOMOGRAM FOR THE PREDICTION OF LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS SUBJECTED TO RADICAL PROSTATECTOMY AND CONCOMITANT LYMPH NODE DISSECTION
23. MP16-01 REPLACING RETUR WITH CYSTOSCOPY IN HIGH-GRADE T1 NMIBC PATIENTS: CONFIRMATORY RESULTS FROM THE HUNIRE TRIAL
24. MP22-13 FRAILTY ADAPTED ERAS PATHWAY FOR PATIENTS WITH BLADDER CANCER REQUIRING SURGERY: THE GLOBAL RADICAL CYSTECTOMY EVALUATION AND MANAGEMENT (GRACEM) STUDY PROTOCOL
25. MP67-03 IMPACT OF NUMBER OF INNER AND OUTER RENORRAPHY STITCHES ON FUNCTIONAL OUTCOMES AFTER ROBOTIC ASSISTED PARTIAL NEPHRECTOMY
26. MP67-11 PREDICTIVE FACTORS OF 60 DAYS DISEASE PERSISTENCE AND 6-12 MONTHS RECURRENCE AFTER MICROWAVE ABLATION TREATMENT FOR SMALL RENAL MASSES: A SINGLE-CENTER INSTITUTIONAL PROSPECTIVE ANALYSIS
27. PD33-04 OFF-CLAMP VERSUS ON-CLAMP ROBOT-ASSISTED PARTIAL NEPHRECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS
28. MP19-13 WHAT HAPPENS TO PATIENTS WITH A PI-RADS 5 LESION AND A NEGATIVE PROSTATE BIOPSY? LONG TERM FOLLOW UP OF A SINGLE INSTITUTIONAL EXPERIENCE
29. MP68-04 ESTIMATING THE IMPACT OF ENHANCED CARE AT MINORITY-SERVING HOSPITALS ON DISPARITIES IN THE TREATMENT OF PROSTATE CANCER
30. MP49-04 IS MULTIPARAMETRIC MRI ALWAYS NEEDED IN BIOPSY-NAÏVE PATIENTS WITH ABNORMAL DIGITAL RECTAL EXAMINATION? A SINGLE-INSTITUTIONAL EXPERIENCE COMBINING CLINICAL AND MICRO-ULTRASONOGRAPHY BASED FACTORS TO OPTIMIZE PROSTATE CANCER DETECTION
31. Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study
32. A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies
33. Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study
34. Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience
35. Impact of a structured rehabilitation program on urinary continence in patients with intermediate high-risk prostate cancer undergoing robotic-assisted laparoscopic prostatectomy.
36. Urological surgery with the Hugo RAS™ System: insights into system adaptability.
37. How to tailor renorrhaphy technique during robot-assisted partial nephrectomy.
38. Robot-Assisted Pyeloplasty with HUGO™ Robotic System: Initial Experience and Optimal Surgical Set-Up at a Tertiary Referral Robotic Center.
39. Robotic partial nephrectomy for hilar renal masses
40. Systematic review on training models for partial nephrectomy
41. Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment?
42. Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project
43. En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study
44. Randomized phase III clinical trial of neoadjuvant intravesical mitomycin C (MMC) treatment in patients with primary treatment-naïve vesical neoplasms: Interim analysis.
45. Prevalence of variant of unknown significance (VUS) in men with prostate cancer who serve as a benchmark for enhanced screening and for personalized therapy.
46. Assessing the mid-term impact of enhanced prostate cancer screening in Caucasian men with germline DNA repair pathogenic variants.
47. A comparative analysis of the HUGOTM robot‐assisted surgery system and the Da Vinci® Xi surgical system for robot‐assisted sacrocolpopexy for pelvic organ prolapse treatment.
48. Retroperitoneal approach for robot-assisted partial nephrectomy: still underused despite the supporting evidence
49. Initial Experience of Robot-Assisted Simple Prostatectomy with Hugo Robot-Assisted Surgery System: Step-by-Step Description of Two Different Techniques
50. A cost analysis in implementing simulation-based training into a novel urology curriculum
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.